KMT2A and acute lymphoblastic leukemia: This is in contrast to the dramatic reduction in transcription produced by PAF1 degradation in SEM (MLL-AF4 ALL) cells but matches the much weaker effect we observed in MM1.S (multiple myeloma) cells.